Overview

Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease

Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the response of itraconazole and terbinafine therapy compared to placebo in patients with Crohn's disease (CD).
Phase:
Phase 2
Details
Lead Sponsor:
Montreal Heart Institute
Treatments:
Hydroxyitraconazole
Itraconazole
Terbinafine